Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIGER: Light Therapy vs BPO for Acne
NCT02698436Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2016
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Percent Change of Global Face Total Acne Lesion Count From Baseline at 12 weeks. Started Mar 2016; status: completed.
Beyond the preview
Go deeper on NCT02698436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02698436.